| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |